Dipeptidyl Aminopeptidases
Editat de Uwe Lendeckel, Dirk Reinhold, Ute Banken Limba Engleză Hardback – 12 apr 2006
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 1353.48 lei 6-8 săpt. | |
| Springer – 15 noi 2014 | 1353.48 lei 6-8 săpt. | |
| Hardback (1) | 1354.99 lei 6-8 săpt. | |
| Springer Us – 12 apr 2006 | 1354.99 lei 6-8 săpt. |
Preț: 1354.99 lei
Preț vechi: 1426.31 lei
-5%
Puncte Express: 2032
Preț estimativ în valută:
239.63€ • 283.58$ • 208.95£
239.63€ • 283.58$ • 208.95£
Carte tipărită la comandă
Livrare economică 03-17 aprilie
Specificații
ISBN-13: 9780387290584
ISBN-10: 0387290583
Pagini: 226
Ilustrații: XXII, 226 p.
Dimensiuni: 162 x 244 x 17 mm
Greutate: 0.51 kg
Ediția:2006 edition
Editura: Springer Us
Locul publicării:New York, NY, United States
ISBN-10: 0387290583
Pagini: 226
Ilustrații: XXII, 226 p.
Dimensiuni: 162 x 244 x 17 mm
Greutate: 0.51 kg
Ediția:2006 edition
Editura: Springer Us
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Structure and Function.- Peptide Substrates of Dipeptidyl Peptidases.- Phosphorus-Containing Inhibitors of Proteolytic Enzymes.- Biochemical Properties of Recombinant Prolyl Dipeptidases DPP-IV and DPP8.- Prediction of Dipeptidyl Peptidase (DP) 8 Structure by Homology Modelling.- Dpiv-Related Enzymes.- Structure and Function in Dipeptidyl Peptidase IV and Related Proteins.- Expression and Function of Dipeptidyl Peptidase IV and Related Enzymes in Cancer.- DP8 and DP9 have Extra-Enzymatic Roles in Cell Adhesion, Migration and Apoptosis.- In Vivo Effects of a Potent, Selective Dppii Inhibitor.- Expression of Dipeptidyl Peptidase IV-Like Enzymes in Human Peripheral Blood Mononuclear Cells.- Dipeptidyl Peptidase 8 Has Post-Proline Dipeptidyl Aminopeptidase and Prolyl Endopeptidase Activities.- Prolyl Endopeptidase Cleaves the Apoptosis Rescue Peptide Humanin and Exhibits an Unknown Post-Cysteine Cleavage Specificity.- Distribution of Dipeptidyl Peptidase Iv-Like Activity Enzymes in Canine and Porcine Tissue Sections by RT-PCR.- Metabolic Disorders.- Relative Contribution of Incretins to the Glucose Lowering Effect of DP IV Inhibitors in Type 2 Diabetes Mellitus (T2DM).- Dipeptidyl Peptidase IV: A Molecular Switch of Vascular Actions of Neuropeptide Y.- Immune Disorders.- Dipeptidylpeptidase IV (DPIV) and Alanyl-Aminopeptidases (AAPs) as a New Target Complex for Treatment of Autoimmune and Inflammatory Diseases—Proof of Concept in a Mouse Model of Colitis.- Dipeptidyl Peptidases and Inflammatory Bowel Disease.- Possible Role of DP IV Inhibitors in Acne Therapy.- Dipeptidyl Peptidase-IV Activity and/or Structure Homologs (DASH): Contributing Factors in the Pathogenesis of Rheumatic Diseases?.- Neuronal Diseases.- Dipeptidyl Peptidase IV (DP IV, CD26) and Aminopeptidase N(APN, CD13) as Regulators of T Cell Function and Targets of Immunotherapy in CNS Inflammation.- CD26/DP IV in T Cell Activation and Autoimmunity.- Cancer.- DPIV/CD26 and FAP in Cancer: A Tale of Contradictions.- Type-II Transmembrane Prolyl Dipeptidases and Matrix Metalloproteinases in Membrane Vesicles of Active Endothelial Cells.- Extra-Enzymatic Roles of DPIV and FAP in Cell Adhesion and Migration on Collagen and Fibronectin.- Role of Neuropeptide Y and Dipeptidyl Peptidase IV in Regulation of Ewing’s Sarcoma Growth.- The Role of CD26/DPP IV in Preservation of Early Pulmonary Graft Function.
Caracteristici
The first comprehensive volume on Dipeptidyl Aminopeptidases that can be marketed to such a wide variety of disciplines (immunology, autoimmune disease, inflammation, neuroscience, drug development/pharmaceutical sciences, and biochemistry), as well as to a variety of clinicians Includes supplementary material: sn.pub/extras